Endonovo Therapeutics Inc (OTCQB:ENDV.PK)

0.046
Delayed Data
As of Feb 21
 -0.0035 / -7.07%
Today’s Change
0.01
Today|||52-Week Range
0.14
-20.69%
Year-to-Date
No recent news for Endonovo Therapeutics Inc.

Today’s Trading

Previous close0.05
Today’s open0.05
Day’s range0.05 - 0.05
Volume881,651
Average volume (3 months)1,364,344
Market cap$15.1M
Data as of 3:58pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)+28.57%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$5.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO, CFO &
Secretary
Alan Brian Collier
President &
Executive VP-Shareholder Relations
Michael Scott Mann
Corporate headquarters
Woodland Hills, California

Forecasts